Interest of Auriculotherapy in Prophylaxis of Migraine and Headache in Patients With Migraines

NCT03036761 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-04-21

No results posted yet for this study

Summary

The aim of the study is to show that auriculotherapy decreases the number of days with painful episodes of migraine and headache after 3 months of treatment

Conditions

  • Headache, Migraine

Interventions

PROCEDURE

Auriculotherapy

3 sessions of auriculotherapy at one month intervals.

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Mireille Michel-Cherqui, MD · Hopital Foch

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Months
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-18
Primary Completion
2020-12-14
Completion
2021-03-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03036761 on ClinicalTrials.gov